Contribution of post-breakfast plasma glucose to the glycemic control of type 2 diabetic patients;Contribuição da glicemia pós-desjejum para o controle glicêmico do paciente com diabetes melito tipo 2

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 1, 2006, Pages 53-59

  Sartori, Maria Salete ^a   Aragon, Flávio Ferrari ^a   Padovani, Carlos Roberto ^a   Pimenta, Walkyria De P ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Glycated hemoglobin; Post breakfast plasma glucose; Postprandial plasma glucose; Type 2 diabetes mellitus

Indexed keywords

EID: 33646742735     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302006000100008     Document Type: Article

References (37)

1. Malerbi DA, Franco LJ, The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. Diabetes Care 1992;15:1509-16.
2. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: The epidemiological evidence. Diabetologia 2001;44:2107-14.
3. th ed. Philadelphia: Saunders; 2003. pp.1509-83.
4. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: A scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003;93:1159-69.
5. Ceriello A. Postprandial hyperglycemia and diabetes complications: Is it time to treat? Diabetes 2005;54:1-7.
6. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40.
7. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 1998;28:687-94.
8. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Seikikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999;22:920-4.
9. Rodrigues BL, Lau N, Burchfield CM, Abbott RD, Sharp DS, Yano LK, et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality. The Honolulu Heart Program. Diabetes Care 1999;22:1262-5.
10. The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999;354:617-21.
11. Malmberg K, for the DIGAMI Study Group. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997;314:1512-5.
12. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(suppl. 2):B21-9.
13. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in Type 2 diabetic patients: Meta-analysis of seven long-term studies. Eur Heart J 2004;25:10-6.
14. Fontbonne A, Eschwège E, Cambien F, Richard J-L, Ducimetière P, Thibult N, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300-4.
15. Beks PHJ, Mackaay AJC, De Vries H, De Neeling JND, Bouter LM, Heine RJ. Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population: The Hoorn Study. Diabetologia 1997;40:290-8.
16. Del Prato S. In search of normoglycaemia in diabetes: Controlling postprandial glucose. Intern J Obes 2002;26(suppl. 1):S9-17.
17. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen M-R. What does postprandial hyperglycaemia mean? Diabetic Med 2004;21:208-13.
18. Davies MJ. Post-prandial hyperglycaemia and prevention of cardiovascular disease. Diabetic Med 2005;22(suppl. 1):6-9.
19. De Venciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237-41.
20. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997;20:1822-6.
21. Soonthorpun S, Rattarasarn C, Leelawattana R, Setasuban W. Postprandial plasma glucose: A good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Res Clin Pract 1999;46:23-7.
22. 1C interrelationships in type 2 diabetes: Implications for treatment and monitoring of metabolic contol. Diabetes Care 2001;24:2023-9.
23. 1C. Diabetes Care 2003;26:881-5.
24. Norman GR, Streiner DL. Biostatistics: The bare essentials. St. Louis: Mosby-Year Book; 1994.
25. Monnier L, Colette C, Rabasa-Lhoret R, Lapinski H, Caubel C, Avignon A, et al. Morning hyperglycemic excursions: A constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 2002;25:737-41.
26. Molnar GD, Taylor WF, Langworthy A. On measuring the adequacy of diabetes regulation: Comparison of continuously monitored blood glucose patterns with values at selected time points. Diabetologia 1974;10:139-43.
27. Bolli GB. The dawn phenomenon: Its origin and contribution to early morning hyperglycemia in diabetes mellitus. Diabetes Metab (Paris) 1988;14:675-86.
28. Lerman-Garber I, López-Ponce A, Flores RAM, Brito-Córdova GX, Velasco-Pérez ML, Villa AR, et al. Comparing easy and accessible parameters of glycemic control in type 2 diabetes. Rev Invest Clínica 2001;53:18-25.
29. Trovati M, Burzacca S, Mularoni E, Massucco P, Cavalot F, Mattiello L, et al. Occurrence of low blood glucose concentrations during the afternoon in Type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: Importance of blood glucose monitoring. Diabetologia 1991;34:662-7.
30. Bouma M, Kriegsman DM, Dekker JH, Kostense PJ, Sonnaville JJ, Heine RJ, et al. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabets Care 1999;22:904-7.
31. American Diabetes Association. Postprandial blood glucose. Consensus Statement. Diabetes Care 2001;24:775-8.
32. 1C does not reflect prandial plasma glucose excursions in type 2 diabetes [letter]. Diabetes Care 2000;23:1859-60.
33. 1C influenced more strongly by preprandial or postprandial glycemia in type 1 diabetes [letter]? Diabetes Care 2002;25:1100-1.
34. 1C in Type 1 diabetes? Diabetic Med 2004;21:468-70.
35. Trovati M, Burzacca S, Mularoni E, Massucco P, Cavalot F, Mattiello L, et al. A comparison of the predictive power for overall blood glucose control of a "good" fasting level in Type diabetic patients on diet or with oral agents. Diabetic Med 1991;9:134-7.
36. Jeffcoate SL. Diabetes control and complications: The role of glycated haemoglobin, 25 years on. Diabetic Med 2004;21:657-65.
37. 1C and glycemic profile, basal- and post-treatment with miglitol, in an area with a Mediterranean diet [letter]. Diabetes Care 2002;25:1896-8.